Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Contraloid - Priavoid

Next Previous
Drug Profile

Contraloid - Priavoid

Alternative Names: Contraloid; Contraloid Acetate; PRI-002; RD 2

Latest Information Update: 28 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Priavoid
  • Developer Charite - Universitatsmedizin Berlin; Priavoid
  • Class Antidementias; Neuroprotectants; Nootropics; Peptides
  • Mechanism of Action Amyloid beta-protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Dementia; Mild cognitive impairment
  • Phase I Alzheimer's disease

Most Recent Events

  • 28 Sep 2024 No recent reports of development identified for phase-I development in Mild-cognitive-impairment(In the elderly, In adults) in Germany (PO, Capsule)
  • 28 Jul 2024 Efficacy, adverse events and pharmacodynamics data from a phase Ib trial in Mild cognitive impairment presented at the Alzheimer's Association International Conference 2024 (AAIC-2024)
  • 01 Dec 2023 Phase-II clinical trials in Dementia in Poland (PO) (NCT06182085)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top